1. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia

   • Tomas Jakobsson
   • Lise-Lotte Vedin
   • Paolo Parini

   Leading Article Open access 02 September 2017 Pages: 1613 - 1621

2. Clinical Assessment and Management of Delirium in the Palliative Care Setting

   • Shirley Harvey Bush
   • Sallyanne Tierney
   • Peter Gerard Lawlor

   Therapy in Practice Open access 01 September 2017 Pages: 1623 - 1643

   

3. Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma

   • Michael D. Jain
   • John Kuruvilla

   Review Article 17 August 2017 Pages: 1645 - 1655

4. Bezlotoxumab: A Review in Preventing Clostridium difficile Infection Recurrence

   • Emma D. Deeks

   Adis Drug Evaluation 01 September 2017 Pages: 1657 - 1663

   

5. Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids

   • Karly P. Garnock-Jones
   • Sean T. Duggan

   Adis Drug Evaluation 12 September 2017 Pages: 1665 - 1675

   

6. Lonoctocog Alfa: A Review in Haemophilia A

   • Zaina T. Al-Salama
   • Lesley J. Scott

   Adis Drug Evaluation Open access 12 September 2017 Pages: 1677 - 1686

7. Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting

   • Young-A Heo
   • Emma D. Deeks

   Adis Drug Evaluation 20 September 2017 Pages: 1687 - 1694

8. Neratinib: First Global Approval

   • Emma D. Deeks

   AdisInsight Report 07 September 2017 Pages: 1695 - 1704

   

9. Enasidenib: First Global Approval

   • Esther S. Kim

   AdisInsight Report 06 September 2017 Pages: 1705 - 1711